Insulin Delivery Devices Market

The report "Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030" is valued at an estimated USD 35.3 billion in 2025. The market is projected to reach USD 52.7 billion by 2030, at a CAGR of 8.3%.

Browse 454 market data Tables and 65 Figures spread through 378 Pages and in-depth TOC on "Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html

The market for insulin delivery devices is steadily increasing, primarily due to the rising number of individuals with diabetes. The global population is also aging, and older individuals are more susceptible to diabetes, leading to greater demand for these devices worldwide. Additionally, increasing government support and favorable reimbursement schemes are boosting the demand for insulin delivery devices, such as insulin pens, insulin pumps, and insulin syringes. For example, many countries, including Germany and France, provide insulin delivery devices under government programs. Furthermore, the growth in research and development activities and strategic partnerships globally contribute to the market's expansion.

By type, the insulin pumps segment is expected to grow at the highest CAGR in the insulin delivery devices market during the forecast period.

The insulin delivery devices market is categorized by type into insulin pens, insulin pumps, insulin pen needles, insulin syringes, and other insulin delivery devices. The insulin pumps segment is anticipated to experience the fastest growth during the forecast period. This growth can be attributed to increasing research and development activities and strategic partnerships worldwide.

Insulin pumps are small, computerized, portable devices that attach to the body and are programmed to deliver specific amounts of insulin continuously throughout the day. They are primarily used by patients who require ongoing insulin delivery. Insulin pumps can be further divided into disposable and reusable models. According to a 2023 report by the University of Alabama at Birmingham (I-JAB), approximately 350,000 individuals in the US currently use insulin pumps. This number is expected to rise, as the technology has shown significant improvements in diabetes management for both adults and children with Type 1 Diabetes (T1D) by enhancing glycemic control and improving quality of life. With the increasing popularity of continuous subcutaneous insulin infusion (CSII), the insulin pumps market is projected to grow during the forecast period.

By application, the type 1 diabetes segment accounted for the largest market share in 2024.

The insulin delivery devices market is categorized into two segments based on application: type 1 diabetes and type 2 diabetes. In 2024, the type 1 diabetes segment held the largest market share. This growth is attributed to the increasing prevalence and incidence of type 1 diabetes worldwide. According to the International Diabetes Federation (IDF) Atlas 2025, approximately 9.15 million individuals globally were diagnosed with clinical type 1 diabetes in 2024. Of this number, 22.3% (about 2.04 million) lived in low-income and lower-middle-income countries.

In terms of age distribution, 1.81 million individuals (19.8%) were under 20 years old, 6.28 million (68.6%) were between 20 and 59 years old, and 1.06 million (11.8%) were 60 years and older. Additionally, 503,000 new diagnoses of type 1 diabetes were reported globally in 2024, with 219,000 of these cases occurring among youth and young adults under the age of 20.

The rising incidence of type 1 diabetes across all age groups, along with increasing diagnosis rates, is driving the demand for innovative and easy-to-use insulin delivery devices. This trend is expected to contribute significantly to the growth of the type 1 diabetes segment within the insulin delivery devices market.

North America dominated the global insulin delivery devices market in 2024.

The insulin delivery devices market is divided into five major regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of the insulin delivery devices market. Several factors contribute to this growth, including the rising incidence of diabetes, increasing government initiatives, and favorable reimbursement schemes.

According to the International Diabetes Federation (IDF) Atlas 2025, the number of adults aged 20 to 79 years with diabetes is 38.5 million in the US, with a prevalence rate of 15.7%. In Canada, 2.8 million adults have diabetes, with a prevalence rate of 9.7%. Additionally, the increasing healthcare expenditure in the region is propelling the market for insulin delivery devices. The IDF Atlas 2025 reports that diabetes-related healthcare expenditure in the US and Canada was USD 327.5 billion and USD 13.7 billion, respectively, in 2024.

Furthermore, growing government support is also boosting market growth. The FDA is dedicated to advancing the innovation of new devices that can enhance the health and quality of life for individuals living with chronic conditions, such as diabetes, through precision medicine approaches. Collectively, these factors are driving the growth of the insulin delivery devices market in the region.

Key Players

Some of the prominent players operating in the market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic, Plc (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), and Eli Lilly and Company (US), among others.

Don’t miss out on business opportunities in Insulin Delivery Device Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/